4.3.2025 | Forbes
The U.S. pharmaceutical industry has temporarily avoided major tariffs, but how long will this last? Dr. Steve Brozak explores the potential risks and consequences of new tariffs on essential drug imports. If imposed, these tariffs could increase costs, exacerbate shortages, and threaten the healthcare system’s stability.
Read the full article in Forbes here: Pharma Dodges The Tariff Bullet – But For How Long?
For more industry insights, follow us on X (@wbbsec) and LinkedIn.
